We’re gearing up for the Super Bowl of the next-gen sequencing field – the Advances in Genome Biology and Technology (AGBT) meeting held annually in Marco Island, Fla. In a typical year, there would be major announcements from the established sequencing vendors at this event, but given that Life Technologies and Illumina already went public with their big news at JP Morgan, and the Roche bid for Illumina will likely still be playing out, the big stories from this year’s meeting will probably revolve around major research findings, technology applications, and what’s going on with the sequencing upstarts. (Oxford Nanopore, for example, will be announcing plans to commercialize its instrument later this year and providing attendees a sneak peek. GnuBio will also be presenting on its desktop sequencer, the iGnuIT 1000.)
As usual, this year’s agenda is chock full of thought-provoking presentations, including a talk by DNAnexus co-founder Arend Sidow, who will be presenting on the use of deep whole-genome sequencing to monitor breast cancer progression (Thursday, Feb. 16, at 4:35pm).
We’ll be there to meet with colleagues, customers, and potential collaborators. We’ll also be presenting two posters on current DNAnexus projects. If you’ll be there, we encourage you to stop by — find out more about us, get a demo, have some wine and cheese, you name it. Here’s a quick preview of what we’ll be showcasing: